|
LY2835219
|
LY2835219
|
1231930-82-7
|
|
N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea
|
N-(3-氯苯基)-N'-[5-[2-(噻吩并[3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲
|
1057249-41-8
|
|
PF-562271
|
N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺
|
717907-75-0
|
|
AMG 900
|
AMG 900
|
945595-80-2
|
|
GSK461364
|
GSK461364
|
929095-18-1
|
|
ZM-447439
|
ZM 447439
|
331771-20-1
|
|
BMS-265246
|
BMS265246
|
582315-72-8
|
|
Rhosin hydrochloride
|
1281870-42-5
|
1281870-42-5
|
|
Flavopiridol
|
2-(2-氯苯基)-5,7-二羟基-8-[(3S,4R)-3-羟基-1-甲基-4-哌啶基]苯并吡喃-4-酮
|
146426-40-6
|
|
CGP60474
|
3-[[4-[2-[(3-氯苯基)氨基]-4-嘧啶基]-2-吡啶基]氨基]-1-丙醇
|
164658-13-3
|
|
CYC-116
|
CYC-116
|
693228-63-6
|
|
Aurora kinase inhibitor-3
|
AURORA KINASE INHIBITOR III
|
879127-16-9
|
|
Indibulin
|
2-(1-(4-氯苄基)-1H-吲哚-3-基)-2-氧代-N-(吡啶-4-基)乙酰胺
|
204205-90-3
|
|
DCPIB
|
DCPIB
|
82749-70-0
|
|
LDC000067
|
(3-(6-(2-甲氧基苯基)嘧啶-4-基氨基)苯基)甲烷磺酰胺
|
1073485-20-7
|
|
CP 94253 dihydrochloride
|
CP 94253盐酸盐
|
845861-39-4
|
|
Sapitinib
|
AZD8931
|
848942-61-0
|
|
BIBO3304 TFA
|
N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate
|
191868-14-1
|
|
Selpercatinib
|
塞卡替尼
|
2152628-33-4
|
|
KU57788(NU7441)
|
8-(4-二苯并噻吩基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮
|
503468-95-9
|
|
FITM
|
4-氟-N-[4-[6-(异丙基氨基)嘧啶-4-基]-1,3-噻唑-2-基]-N-甲基苯甲酰胺
|
932737-65-0
|
|
Osimertinib mesylate
|
AZD9291(甲磺酸盐)
|
1421373-66-1
|
|
NI-57
|
NI-57
|
1883548-89-7
|
|
Derazantinib
|
德拉赞替尼
|
1234356-69-4
|
|
Fostamatinib Disodium
|
R788(FOSTAMATINIB DISODIUM)
|
1025687-58-4
|
|
CGS 15943
|
CGS 15943
|
104615-18-1
|
|
Dovitinib
|
4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮
|
405169-16-6
|
|
MK-5108 (VX-689)
|
MK-5108 (VX-689)
|
1010085-13-8
|
|
CCT196969
|
CB93134226
|
1163719-56-9
|
|
Cediranib
|
西地尼布
|
288383-20-0
|
|
AZD-4547
|
AZD-4547
|
1035270-39-3
|
|
TSU-68
|
orantinib
|
252916-29-3
|
|
Varlitinib
|
泛EGFR小分子抑制剂(VARLITINIB)
|
845272-21-1
|
|
Pemigatinib
|
培米加替尼
|
1513857-77-6
|
|
Gilteritinib
|
吉列替尼
|
1254053-43-4
|
|
（±）-Marinopyrrole A
|
(±)-MARINOPYRROLE A
|
1227962-62-0
|
|
Dovitinib (TKI-258) Dilactic Acid
|
多韦替尼二乳酸
|
852433-84-2
|
|
Sorafenib
|
索拉非尼
|
284461-73-0
|
|
ASP-3026
|
ASP3026
|
1097917-15-1
|
|
OSI-420
|
2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧基]乙醇
|
183321-86-0
|
|
AA41612
|
化合物AA41612
|
433690-62-1
|
|
TAE684
|
NVP-TAE684
|
761439-42-3
|
|
Osilodrostat
|
LCI 699
|
928134-65-0
|
|
R788
|
福他替尼
|
901119-35-5
|
|
EGFR inhibitor
|
EGFR INHIBITOR
|
879127-07-8
|
|
Nintedanib esylate
|
尼达尼布乙磺酸盐
|
656247-18-6
|
|
Motolimod
|
MOTOLIMOD
|
926927-61-9
|
|
LY2801653
|
梅沙替尼
|
1206799-15-6
|
|
K-Ras(G12C) inhibitor 12
|
K-RAS(G12C) INHIBITOR 12
|
1469337-95-8
|
|
Pexidartinib
|
培西达替尼
|
1029044-16-3
|
|
Nintedanib
|
尼达尼布
|
656247-17-5
|
|
Ki8751
|
Ki8751
|
228559-41-9
|
|
Afatinib dimaleate
|
双马来酸盐阿法替尼
|
850140-73-7
|
|
LE 135
|
LE 135
|
155877-83-1
|
|
Linifanib
|
利尼伐尼
|
796967-16-3
|
|
Src Inhibitor-1
|
7-二甲氧基-N-(4-苯氧基苯基)- 氨基喹唑啉
|
179248-59-0
|
|
Tropifexor
|
Tropifexor
|
1383816-29-2
|
|
4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate
|
瑞格非尼一水合物
|
1019206-88-2
|
|
3,5-Bis[(4-nitrophenyl)methylene]-2,3,5,6-tetrahydro-4H-thiopyran-4-one-1,1-dioxide;3,5-bis((4-Nitrophenyl)methylene)-1,1-dioxide;tetrahydro-4H-thiopyran-4-one;NSC-144303;Ubiquitin Isopeptidase Inhibitor I;tetrahydro-3,5-bis[(4-nitrophenyl)methylene]-4H-t
|
108477-18-5
|
108477-18-5
|
|
GNE-0877
|
GNE-0877
|
1374828-69-9
|
|
Favipiravir
|
法匹拉韦
|
259793-96-9
|
|
GSK-J4
|
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯
|
1373423-53-0
|
|
Carfilzomib
|
卡非佐米
|
868540-17-4
|
|
UC2288
|
1394011-91-6
|
1394011-91-6
|
|
Lopinavir
|
洛匹那韦
|
192725-17-0
|
|
Telaprevir
|
特拉匹韦（VX-950）
|
402957-28-2
|
|
MG-132
|
MG132,蛋白酶体抑制剂
|
133407-82-6
|
|
PF 05190457
|
PF-05190457, CID 58438464
|
1334782-79-4
|
|
RS 67333 hydrochloride
|
RS 67333盐酸盐
|
168986-60-5
|
|
ML 179
|
ML-179
|
1883548-87-5
|
|
Letermovir
|
莱特莫韦
|
917389-32-3
|
|
L-371257
|
L371,257
|
162042-44-6
|
|
EC-23
|
4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)ethynyl)-benzoicacid
|
104561-41-3
|
|
Ibrutinib
|
依鲁替尼 Ibrutinib(PCI-32765)
|
936563-96-1
|
|
PRX 07034
|
5-氯-2,3-二甲氧基-Α-甲基-N-[2-(甲基磺酰基)-5-(1-哌嗪基)苯基]-苯甲胺盐酸盐
|
903580-39-2
|
|
LYN-1604
|
蓝木定制的新产品
|
2088939-99-3
|
|
GSK-3 Inhibitor XIII
|
(5-METHYL-1H-PYRAZOL-3-YL)-(2-PHENYLQUINAZOLIN-4-YL)AMINE
|
404828-08-6
|
|
CYM 5520
|
1-[2-(1-Benzyl-2,5-dimethyl-1H-pyrrol-3-yl)-2-oxo-ethyl]-6-oxo-1,6-dihydro-pyridine-3-carbonitrile
|
1449747-00-5
|
|
TCS 1102
|
TCS 1102
|
916141-36-1
|
|
MPP dihydrochloride
|
MPP 二盐酸盐
|
911295-24-4
|
|
AH 6809
|
6-异丙氧基-9-氧代氧杂蒽-2-羧酸
|
33458-93-4
|
|
Trametinib
|
曲美替尼
|
871700-17-3
|
|
Trandolaprilat
|
群多普利
|
87679-71-8
|
|
K-115
|
(2S)-1-[(4-氟-5-异喹啉基)磺酰基]六氢-2-甲基-1H-1,4-二氮杂卓单盐酸盐二水合物
|
887375-67-9
|
|
2-undecyl-thiazolidine-4-carboxylic acid
|
2-UNDECYL-THIAZOLIDINE-4-CARBOXYLIC ACID
|
298186-80-8
|
|
Necrosulfonamide
|
N-[4-[[(3-甲氧基吡嗪基)氨基]磺酰基]苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺
|
432531-71-0
|
|
Raltegravir
|
雷特格韦
|
518048-05-0
|
|
Thiamet G
|
THIAMET G
|
1009816-48-1
|
|
GsMTx4 TFA
|
GSMTX4 TFA
|
|
|
BMS 986187
|
BMS 986187
|
684238-37-7
|
|
PHCCC
|
N-苯基-7-(羟基亚胺基)环丙烯并[B]苯并吡喃-1A-甲酰胺
|
179068-02-1
|
|
CUDA
|
CUDA
|
479413-68-8
|
|
MYCi361
|
MYCI361
|
2289690-31-7
|
|
BVT 948
|
4-羟基-3,3-二甲基-2H-苯并[G]吲哚-2,5(3H)-二酮
|
39674-97-0
|
|
GSK 2018682
|
CPD1224
|
1034688-30-6
|
|
CAY10404
|
3-(4-METHYLSULPHONYLPHENYL)-4-PHENYL-5-TRIFLUOROMETHYLISOXAZOLE
|
340267-36-9
|
|
GC376
|
GC376
|
1416992-39-6
|
|
SHA 68
|
SHA 68
|
847553-89-3
|
|
TCS-OX2-29
|
TCS-OX2-29 HCl
|
1610882-30-8
|
|
Alectinib
|
艾乐替尼
|
1256580-46-7
|